Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121808) titled 'The effective dose for successful insertion of a laryngeal mask and impact on discharge time of alfentanil combined with remimazolam besylate in ambulatory hysteroscopic surgery:a prospective,randomized,controlled clinical trial' on April 3.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guabgzhou First People's Hospital
Condition:
Endometrial polyps
Intervention:
Trial 1:Alfentanil group (Group A)
Modified Dixon sequential method: After 3 minutes of preoxygenation, remimazolam besylate 0.2 mg/kg was slowly administered intravenously over 60 seconds, followed by alfentanil intrav...